Table 3.
Laboratory and imaging abnormalities in infants with symptomatic congenital CMV infection identified based on newborn screening (screened) or clinical suspicion (referred)
| Screened (N=78) | Referred (N=100) | P-value | |
|---|---|---|---|
| Positive/Total Examined (%) | |||
| Elevated Aspartate Aminotransferase (>80 IU/mL) | 17/31 (55) | 50/67 (75) | 0.05 |
| Thrombocytopenia (<100,000/mm3) | 22/58 (38) | 64/89 (72) | <0.001 |
| Direct Hyperbilirubinemia (>2mg/dL) | 22/48 (46) | 44/75 (59) | NS |
| Head CT Abnormalities | 15/21 (71) | 39/53 (74) | NS |
| Calcifications | 10/21 (48) | 31/53(58) | NS |